Amanote Research

Amanote Research

    RegisterSign In

Genomic Alterations of ERBB Receptors in Cancer: Clinical Implications

Oncotarget - United States
doi 10.18632/oncotarget.22825
Full Text
Open PDF
Abstract

Available in full text

Categories
Oncology
Date

December 1, 2017

Authors
Rosalin MishraAriella B. HankerJoan T. Garrett
Publisher

Impact Journals, LLC


Related search

ERBB-Receptors and Drug Response in Breast Cancer

1997English

Role of ErbB Receptors in Cancer Cell Migration and Invasion

Frontiers in Pharmacology
Pharmacology
2015English

Genomic Copy Number Alterations in Serous Ovarian Cancer

2018English

Identification of Genomic Alterations in Pancreatic Cancer Using Array-Based Comparative Genomic Hybridization

PLoS ONE
Multidisciplinary
2014English

Immune Responses to All ErbB Family Receptors Detectable in Serum of Cancer Patients

Oncogene
Cancer ResearchGeneticsMolecular Biology
1999English

EGFR Genomic Alterations in Cancer: Prognostic and Predictive Values

Frontiers in Bioscience - Elite
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2009English

Inactive ERBB Receptors Cooperate With Reactive Oxygen Species to Suppress Cancer Progression

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2013English

Concordance of Genomic Alterations Between Primary and Recurrent Breast Cancer

Molecular Cancer Therapeutics
Cancer ResearchOncology
2014English

Implications of Chemokine Receptors and Inflammatory Lipids in Cancer

ImmunoTargets and Therapy
AllergyImmunology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy